Loading
Latest filing published 10 Mar 2026 for Heidelberg Pharma AG, €7,418. Read the official filing
Dr. Birgit Kudlek appears in our data through filings on Heidelberg Pharma AG shares, published by BaFin. We count 2 filings, every one of them for a trade on 9 March 2026.
Sales make up the whole of the open-market record (2 sales, €14k).
The record was last updated on 10 March 2026 with an open-market sale (€7,418) in Heidelberg Pharma AG. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from BaFin disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations